$EKNL is on the edge of a HUGE breakout that can see prices

New Post Public Reply Private Reply Replies (0) Message Board
Arbel

$EKNL is on the edge of a HUGE breakout that can see prices soaring to multi-dollar land with KEY updates the company is expected to release from their marketing efforts from the recent Medical Conference in London – December is typically the best market gainer month if looking at the average returns over 40 years.

Interesting enough, the chart below shows the market indices performance by month with December booking the highest return month – these stocks made up primarily of large cap stocks but have a direct correlation impact on the penny stock market. With solid long term plays like EKNL, investors will definitely feel the December effect just as DROP did in 2011 reaching our $1.25 target bang on! With key breakout news ready to be unleashed, and super thin stock inventory, EKNL is primed for the biggest month on record!


The key to MEGA gains for EKNL in December is breakout trigger news and EKNL already hinted several times what the possible news can be – and we definitely expect it at any time!

We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.

“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-internation...00594.html

This is definitely a very strong statement by the company to make, and making it is a solid hint that several Major contracts are practically done and ready to be unleashed. We are on HIGH ALERT for an update on these major contacts.

Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.

No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.

The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.

EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.

EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.

No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.

EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.

And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.

There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.50 and holding solid to over 1,200% gains for over 2 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.



Key points that make EKNL an XTREME breakout play:

1) No dilution or insiders selling any time soon and especially at these super low prices.

2) Share buyback in effect. Definitely the reason here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company.

3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT. We expect this number to significantly reduce as the company begins their buyback program.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 3

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 3

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading
Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 2

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
MADD, Uber Rally at Capital Invitational for Safe Choices

Updated Category News Views 3

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Continue Reading
AllyGPO Shines as Top Innovator in Health Tech

Updated Category News Views 3

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Continue Reading
VitalCore Pioneers Jail Behavioral Health Expansion

Updated Category News Views 2

The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...

Continue Reading
Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 1

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading
Stoke Space Raises $1B; XTEND AI Hits NYSE

Updated Category News Views 2

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Continue Reading
IDX Expands, Enhances Team Amid 56% H1 Growth

Updated Category News Views 1

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 1

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Underrated Stocks: Insights on Market Opportunities

Updated Category News Views 251

Underrated Stocks Capturing Investor Attention Each week, a fresh selection of stocks emerges that escapes the typical spotlight but presents ample investment opportunities. Among these stocks, some are generating noteworthy buzz among savvy investors who are deeply analyzing market trends and company performances. Understanding the Nature of Undervalued Stocks Investors...

Continue Reading
Housing Market Insights: A Closer Look at Recent Trends

Updated Category News Views 102

Understanding the Current State of the Housing Market The U.S. housing market has shown mixed signals, as reflected in the latest data from the S&P Cotality Case-Shiller Index. The national index, along with the 20-City Composite and the 10-City Composite, presented year-over-year growth of 1.9%, 2.1%, and 2.6%, respectively. These figures indicate ongoing, albeit...

Continue Reading
Elon Musk's Vision for AI Brains: Challenging Nvidia

Updated Category News Views 128

Elon Musk's Ambitious AI Vision Elon Musk has recently introduced a bold objective for his AI venture, xAI. The ambitious target is to deploy the equivalent of 50 million Nvidia Corp's NVDA H100 GPUs, the prevailing industry standard for artificial intelligence processing, within the next five years. Musk promises that these units will not only replicate the capabilities...

Continue Reading
Exploring the Future of the PCB Market: Growth and Trends

Updated Category News Views 234

Understanding the Growth of the PCB Market The global Printed Circuit Board (PCB) market is witnessing transformative growth. As we look towards the future, the market is set to increase by an impressive USD 26.8 billion from 2025 to 2029. This expansion reflects a compound annual growth rate (CAGR) that exceeds 6.2%. The driving force behind this ascent is the rising...

Continue Reading
Incyte's Tafasitamab Data Shows Promise for Follicular Lymphoma

Updated Category News Views 174

Incyte's Promising Findings on Tafasitamab in Lymphoma Treatment Incyte, a global biopharmaceutical company, recently revealed compelling data from the inMIND Phase 3 trial concerning tafasitamab (Monjuvi), a monoclonal antibody that targets CD19. These results highlight a significant advancement in treating patients with relapsed or refractory follicular lymphoma (FL), a...

Continue Reading